Y. Arai

Clinical Significance of Continuable Treatment with Nintedanib Over 12 Months for Idiopathic Pulmonary Fibrosis in a Real-World Setting

Kazuhisa Takahashi, S. Togo, Motoyasu Kato, 2021, Drug design, development and therapy.

The Synergetic Effect of Sitafloxacin-Arbekacin Combination in the Mycobacteroides abscessus Complex

Kazuhisa Takahashi, T. Miida, S. Togo, 2021 .

Serum Lactate Dehydrogenase Level As a Predictor Of Survival For Patients With Acute Exacerbation of Idiopathic Interstitial Pneumonias Undergoing Polymyxin B-Immobilized Fiber Column-Direct Hemoperfusion

Kazuhisa Takahashi, A. Azuma, S. Togo, 2021 .

A Case of Tuberculosis-related Cerebral Venous Sinus Thrombosis and Pulmonary Thromboembolism Successfully Treated with Edoxaban

Kazuhisa Takahashi, Y. Terajima, M. Sekiya, 2022, Respiratory medicine case reports.

Transformation from adenocarcinoma to squamous cell lung carcinoma with MET amplification after lorlatinib resistance: A case report

Kazuhisa Takahashi, A. Kondo, H. Ninomiya, 2021, Thoracic Cancer.

The synergetic effect of sitafloxacin–arbekacin combination in the Mycobacterium abscessus species

Y. Tabe, T. Miida, T. Naito, 2023, Scientific Reports.

Prognostic differences among patients with idiopathic interstitial pneumonias with acute exacerbation of varying pathogenesis: a retrospective study

Kazuhisa Takahashi, R. Koyama, K. Miura, 2019, Respiratory Research.

Nintedanib administration after the onset of acute exacerbation of interstitial lung disease in the real world

Kazuhisa Takahashi, S. Togo, Motoyasu Kato, 2023, Scientific Reports.